NASH - Nonalcoholic Steatohepatitis Completed Phase 1 Trials for Tilmanocept (DB15373)

IndicationStatusPhase
DBCOND0088313 (NASH - Nonalcoholic Steatohepatitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03332940An Evaluation of the Safety of Intravenous Tc 99m Tilmanocept and a Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASHDiagnostic